The growing demand for controlled immunological research and therapeutic design has spurred significant improvements in recombinant cytokine generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently produced using various expression systems, including prokaryotic hosts, higher cell populations, and baculov